These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26860639)

  • 21. Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.
    Dean B; Gibbons AS; Tawadros N; Brooks L; Everall IP; Scarr E
    Mol Psychiatry; 2013 Jul; 18(7):767-73. PubMed ID: 22801413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity maturation of single-domain antibodies by yeast surface display.
    Koide A; Koide S
    Methods Mol Biol; 2012; 911():431-43. PubMed ID: 22886267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of a human anti-epidermal growth factor receptor Fab antibody, EG-19-11, with subnanomolar affinity from naïve immunoglobulin repertoires using a hierarchical antibody library system.
    Hur BU; Yoon JB; Liu LK; Cha SH
    Immunol Lett; 2010 Nov; 134(1):55-61. PubMed ID: 20797408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of similar single domain antibodies from two immune VHH libraries obtained from two alpacas by using different selection methods.
    Li T; Vandesquille M; Bay S; Dhenain M; Delatour B; Lafaye P
    Immunol Lett; 2017 Aug; 188():89-95. PubMed ID: 28690185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid and simple pipeline for synthesis of mRNA-ribosome-V(H)H complexes used in single-domain antibody ribosome display.
    Bencurova E; Pulzova L; Flachbartova Z; Bhide M
    Mol Biosyst; 2015 Jun; 11(6):1515-24. PubMed ID: 25902394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.
    Ames RS; Tornetta MA; McMillan LJ; Kaiser KF; Holmes SD; Appelbaum E; Cusimano DM; Theisen TW; Gross MS; Jones CS
    J Immunol; 1995 Jun; 154(12):6355-64. PubMed ID: 7759873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Nanobody Scaffold Optimized for Bacterial Expression and Suitable for the Construction of Ribosome Display Libraries.
    Ferrari D; Garrapa V; Locatelli M; Bolchi A
    Mol Biotechnol; 2020 Jan; 62(1):43-55. PubMed ID: 31720928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a progesterone-binding, three-domain antibody fragment (VH/K) expressed in Escherichia coli.
    He M; Kang AS; Hamon M; Humphreys AS; Gani M; Taussig MJ
    Immunology; 1995 Apr; 84(4):662-8. PubMed ID: 7790041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
    Venturi M; Seifert C; Hunte C
    J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
    Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
    J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats.
    Miller A; Carr S; Rabbitts T; Ali H
    MAbs; 2020; 12(1):1752529. PubMed ID: 32316838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency.
    Scallon B; Cai A; Radewonuk J; Naso M
    Mol Immunol; 2004 May; 41(1):73-80. PubMed ID: 15140577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of 2'-amino-modified RNA aptamers for human TNFalpha.
    Yan X; Gao X; Zhang Z
    Genomics Proteomics Bioinformatics; 2004 Feb; 2(1):32-42. PubMed ID: 15629041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
    Maynard JA; Maassen CB; Leppla SH; Brasky K; Patterson JL; Iverson BL; Georgiou G
    Nat Biotechnol; 2002 Jun; 20(6):597-601. PubMed ID: 12042864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel protein engineering strategy for creating highly receptor-selective mutant TNFs.
    Nomura T; Abe Y; Kamada H; Inoue M; Kawara T; Arita S; Furuya T; Yoshioka Y; Shibata H; Kayamuro H; Yamashita T; Nagano K; Yoshikawa T; Mukai Y; Nakagawa S; Taniai M; Ohta T; Tsunoda S; Tsutsumi Y
    Biochem Biophys Res Commun; 2009 Oct; 388(4):667-71. PubMed ID: 19682974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.
    Muda M; Gross AW; Dawson JP; He C; Kurosawa E; Schweickhardt R; Dugas M; Soloviev M; Bernhardt A; Fischer D; Wesolowski JS; Kelton C; Neuteboom B; Hock B
    Protein Eng Des Sel; 2011 May; 24(5):447-54. PubMed ID: 21498564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [One amino acid mutation in an anti-CD20 antibody fragment that affects the yield bacterial secretion and the affinity].
    Liu YX; Xiong DS; Fan DM; Shao XF; Xu YF; Zhu ZP; Yang CZ
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):272-6. PubMed ID: 15969005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.